CELL INTELLIGENCE · 肿瘤细胞治疗研究

iPSCs 在 BCMA 靶向治疗多发性骨髓瘤中的现状与前景

The Current Landscape and Prospects of iPSCs in BCMA-targeted Therapy for Multiple Myeloma.

多发性骨髓瘤（MM）是一种难以治疗的血浆细胞恶性肿瘤，其发病机制具有异质性，预后较差。

癌症之外的 CAR 工程化细胞治疗：重编程纤维化和免疫介导炎症

CAR-Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune-Mediated Inflammation.

多发性骨髓瘤 CAR-NK 细胞治疗的最新进展：细胞来源与靶抗原的综合综述

State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens.

CAR-T 细胞治疗血液系统恶性肿瘤的进展

Progress on CAR-T cell therapy for hematological malignancies.